Sloan Devlin is currently an associate professor in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. She received her A.B. degree in chemistry from Harvard College in 2006, where she conducted research in the laboratory of Andrew Myers. She earned her Ph.D. in 2012 from Stanford University under the direction of Professor Justin Du Bois. Her graduate work focused on the total synthesis of the potent voltage-gated sodium ion channel agonist batrachotoxin as well as the development of novel rhodium-catalyzed C–H insertion methodology. In 2012, Sloan joined the lab of Professor Michael Fischbach at the University of California, San Francisco as a postdoctoral fellow. Her research in the Fischbach lab involved elucidating biosynthetic pathways and biological activities for small molecules produced by human-associated bacteria. Sloan joined the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School as an Assistant Professor in Fall 2016. Sloan’s current work focuses on leveraging expertise in organic chemistry, analytical chemistry, biochemistry, microbiology, cell biology, and gnotobiotic in vivo experiments to understand how human gut bacteria contribute to health and disease. She is the recipient of a 2021 Alfred P. Sloan Research Fellowship in chemistry and a 2018 NIH Maximizing Investigators' Research Award (MIRA).